SCHEMBL19794364

SCHEMBL19794364

CC(C)(C)c1ccnc(-c2ccc(-c3ccccc3-c3cc(-c4ccccc4-c4ccc(-c5cc(C(C)(C)C)ccn5)cc4)cc(-c4ccccc4-c4ccc(-n5cnc6cc7c(cc65)C5CCC7CC5)cc4)c3)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
HTT P42858 3/20 0.38
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.37
NPSR1 Q6W5P4 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
PPP1CA P62136 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
GABRA1 P14867 4/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTK2B Q14289 1/20 0.36
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794365 0.81 HTT (0.38) HTTMAPTKMT2ANPSR1CYP1A2
SCHEMBL21398049 0.77 CHRNB2 (0.45) CHRNB2CHRNA4HTTMAPTKMT2A
SCHEMBL19794405 0.76 NPC1 (0.40) KMT2AALDH1A1RAB9A
SCHEMBL18015301 0.71 NPC1 (0.44) KMT2AALDH1A1RAB9ASMN1; SMN2
SCHEMBL18015600 0.71 TRPV1 (0.46) MAPTKMT2ANPSR1CYP1A2CYP2C9
SCHEMBL19794448 0.71 TRPV1 (0.46) MAPTKMT2ANPSR1CYP1A2CYP2C9
SCHEMBL19933667 0.71 FAAH (0.39) KMT2AALDH1A1RAB9A
SCHEMBL19780912 0.71 ADRA2A (0.35) KMT2ARAB9A
SCHEMBL18015356 0.70 PIM1 (0.37) KMT2AALDH1A1RAB9A
SCHEMBL18015277 0.70 NPC1 (0.36) MAPTKMT2ANPSR1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC CHRNB2 2306/4885CHRNA4 831/4885HTT 1728/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 CHRNB2 1688/4885CHRNA4 1232/4885HTT 1827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.